
Last Posted: May 20, 2022
- Paying for artificial intelligence in medicine
RB Parikh et al, NPJ Digital Medicine, May 20, 2022 - A Unified Framework on Generalizability of Clinical Prediction Models.
Wan Bohua et al. Frontiers in artificial intelligence 2022 5872720 - Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review.
Kompa Benjamin et al. Drug safety 2022 45(5) 477-491 - Assessing the potentiality of algorithms and artificial intelligence adoption to disrupt patient primary care with a safer and faster medication management: a systematic review protocol.
Oliva Antonio et al. BMJ open 2022 12(5) e057399 - Automated Drug Coding Using Artificial Intelligence: An Evaluation of WHODrug Koda on Adverse Event Reports.
Meldau Eva-Lisa et al. Drug safety 2022 45(5) 549-561 - Evaluation of the Effect of Patient Education and Strengthening Exercise Therapy Using a Mobile Messaging App on Work Productivity in Japanese Patients With Chronic Low Back Pain: Open-Label, Randomized, Parallel-Group Trial.
Itoh Naohiro et al. JMIR mHealth and uHealth 2022 10(5) e35867 - FDCNet: Presentation of the Fuzzy CNN and Fractal Feature Extraction for Detection and Classification of Tumors.
Molaei Sepideh et al. Computational intelligence and neuroscience 2022 20227543429 - Industry Perspective on Artificial Intelligence/Machine Learning in Pharmacovigilance.
Kassekert Raymond et al. Drug safety 2022 45(5) 439-448 - Integrating Ethics and Career Futures with Technical Learning to Promote AI Literacy for Middle School Students: An Exploratory Study.
Zhang Helen et al. International journal of artificial intelligence in education 2022 1-35 - Intelligent Telehealth in Pharmacovigilance: A Future Perspective.
Edrees Heba et al. Drug safety 2022 45(5) 449-458
More
Search Result Summary
- CDC Information (3)
- NIH Information (6)
- CDC Publications (3)
- COVID-19 (1499)
- Human Genome Epidemiologic Studies (6)
- GWAS Studies (0)
- Human Genomics Translation/Implementation Studies (1056)
- Genomic Tests Evidence Synthesis (154)
- Genomic Tests Guidelines (21)
- Tier-Classified Guidelines (0)
- Non-Genomics Precision Health (2577)
- Pathogen Advanced Molecular Detection (12)
- State Public Health Genomics Programs (0)
- Ethical/Legal and Social Issues (ELSI) (91)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2021
- Page last updated:May 23, 2022
- Content source: